Literature DB >> 7736873

Treatment of benign anal disease with topical nitroglycerin.

S R Gorfine1.   

Abstract

PURPOSE: Fissure-in-ano and acutely thrombosed external hemorrhoids are common, benign anal conditions, usually characterized by severe anal pain. Internal anal sphincter hypertonia appears to play a role in the etiology of this pain. Nitric oxide has recently been identified as the "novel biologic messenger" that mediates the anorectal inhibitory reflex in humans. This report documents a therapeutic role for nitroglycerin, a nitric oxide donor, in the treatment of acutely thrombosed external hemorrhoids and anal fissure.
METHODS: Five patients with thrombosed external hemorrhoids and fifteen patients with anal fissure or ulcer were identified. A treatment regimen that included 0.5 percent nitroglycerin ointment applied topically to the anus was instituted. After one week of therapy, all patients were re-examined and questioned regarding pain relief and side effects of treatment. Fissure patients were followed for eight weeks or until healing occurred.
RESULTS: All patients reported dramatic relief of anal pain following application of nitroglycerin. Pain relief lasted from two to six hours. Complete healing of fissures occurred within two weeks in ten patients and within one month in two patients. One patient, whose fissure had not healed completely within two weeks requested surgical sphincterotomy. Two patients remained with persistent anal ulcers despite two months of therapy. Both, however, were pain-free. Side effects were limited to transient headache in 7 of 20 patients.
CONCLUSION: Topically applied nitroglycerin ointment appears to have a therapeutic role in the treatment of thrombosed external hemorrhoids and anal fissure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7736873     DOI: 10.1007/bf02148842

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  20 in total

1.  Topical nitrates potentiate the effect of botulinum toxin in the treatment of patients with refractory anal fissure.

Authors:  J Lysy; Y Israelit-Yatzkan; M Sestiery-Ittah; S Weksler-Zangen; D Keret; E Goldin
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 2.  Neuromyogenic properties of the internal anal sphincter: therapeutic rationale for anal fissures.

Authors:  R Bhardwaj; C J Vaizey; P B Boulos; C H Hoyle
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

Review 3.  Pharmacologic treatment of anal fissure with botoxin, diltiazem, or bethanechol.

Authors:  Robin Phillips
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

Review 4.  A review of chronic anal fissure management.

Authors:  E E Collins; J N Lund
Journal:  Tech Coloproctol       Date:  2007-08-03       Impact factor: 3.781

5.  Glyceryl trinitrate is a novel inhibitor of quorum sensing in Pseudomonas aeruginosa.

Authors:  Hisham A Abbas; Moutaz A Shaldam
Journal:  Afr Health Sci       Date:  2016-12       Impact factor: 0.927

6.  [1997 gastroenterology update--I].

Authors:  W Fischbach; S S Gro; J Schölmerich; C Ell; P Layer; W E Fleig; H Zirngibl
Journal:  Med Klin (Munich)       Date:  1998-02-15

7.  Combined approach in the treatment of chronic anal fissures.

Authors:  S Vershenya; J Klotz; A Joos; D Bussen; A Herold
Journal:  Updates Surg       Date:  2015-04-21

Review 8.  External haemorrhoidal thrombosis: evidence for current management.

Authors:  K K W Chan; J D R Arthur
Journal:  Tech Coloproctol       Date:  2012-10-19       Impact factor: 3.781

9.  Bilateral deep peroneal nerve paralysis following kerosene self-injection into external hemorrhoids.

Authors:  Khalil Rostami; Esmaeil Farzaneh; Hassan Abolhassani
Journal:  Case Rep Med       Date:  2010-09-29

10.  Optimal treatment duration of glyceryl trinitrate for chronic anal fissure: results of a prospective randomized multicenter trial.

Authors:  G Gagliardi; A Pascariello; D F Altomare; F Arcanà; D Cafaro; F La Torre; P De Nardi; L Basso; I De Stefano; V J Greco; L Vasapollo; A Amato; A Pulvirenti D'Urso; D Aiello; A Bove
Journal:  Tech Coloproctol       Date:  2010-07-15       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.